You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (206)

Journals (0)

1-10 of 206 results for Fixed combination products

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Similarities and Differences between the United States and Europe in the Development of Fixed Combination Products for the Treatment of Hypertension

Retricted access

Other

First published 2001-4

Similarities and Differences between the United States and Europe in the Development of Fixed Combination Products for the Treatment of Hypertension

John Alexander, Kurt Püchler

Therapeutic Innovation & Regulatory Science

Select article: Fixed dose-combination products in psychiatry: Systematic review and meta-analysis

Retricted access

Review article

First published 2015-5

Fixed dose-combination products in psychiatry: Systematic review and meta-analysis

Saeed Farooq, Surendra P Singh

Journal of Psychopharmacology

Select article: Combination Products Today: An Update on a New Fixed Combination

Retricted access

Research article

First published 2007-7

Combination Products Today: An Update on a New Fixed Combination

I. Bossowska

European Journal of Ophthalmology

Select article: Analysis of Fixed-Dose Combination Products Approved by the US Food and Drug Administration,2010-2015

Retricted access

Research article

First published 2017-1

Analysis of Fixed-Dose Combination Products Approved by the US Food and Drug Administration,2010-2015

Kyu Chan Kwon, Chulung Lee

Therapeutic Innovation & Regulatory Science

Select article: Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

Retricted access

Research article

First published 2019

Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

Ole Jannik Bjerrum, Sascha Eichendorff, Nada Bassam Alkis

Therapeutic Innovation & Regulatory Science

Select article: Does the Fixed Combination of Bimatoprost/Timolol Really Produce a Better Benefit/Risk Balance than the Fixed Combination of Latanoprost/Timolol?

Retricted access

Other

First published 2010-1

Does the Fixed Combination of Bimatoprost/Timolol Really Produce a Better Benefit/Risk Balance than the Fixed Combination of Latanoprost/Timolol?

Javier Soto, Silvia Díaz

European Journal of Ophthalmology

Select article: Bioavailability of paracetamol,phenylephrine hydrochloride and guaifenesin in a fixed-combination syrup versus an oral reference product

Open access

Research article

First published 2014-4

Bioavailability of paracetamol,phenylephrine hydrochloride and guaifenesin in a fixed-combination syrup versus an oral reference product

Annick Janin, Joelle Monnet

Journal of International Medical Research

Select article: A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products

Free access

Review article

First published 2018-3

A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products

Wesley Nuffer, Ashley Guesnier, Jennifer M. Trujillo

Therapeutic Advances in Endocrinology and Metabolism

Select article: Development of Technology for Production of Second Generation Biofuel Ethanol from Bagasse

Retricted access

Research article

First published 2013-8

Development of Technology for Production of Second Generation Biofuel Ethanol from Bagasse

Jagdish Singh, Prashant Sharma

Asian Journal of Water,Environment and Pollution

Select article: A Double-Masked,Randomized,Parallel Comparison of a Fixed Combination of Bimatoprost 0.03%/Timolol 0.5% with Non-Fixed Combination use in Patients with Glaucoma or Ocular Hypertension

Retricted access

Research article

First published 2007

A Double-Masked,Randomized,Parallel Comparison of a Fixed Combination of Bimatoprost 0.03%/Timolol 0.5% with Non-Fixed Combination use in Patients with Glaucoma or Ocular Hypertension

A. Hommer, Ganfort® Investigators Group I

European Journal of Ophthalmology

1
2
3
•••
21
10 / page

Article type

Publication date

Subjects

Access